Navigation Links
Retrospective Study Confirms Bovine Carotid Artery Biologic Graft Outperforms Expanded Polytetrafluoroethylene for Hemodialysis Access
Date:4/3/2017

NORTH BRUNSWICK, N.J., April 3, 2017 /PRNewswire/ -- A retrospective review of 120 consecutive hemodialysis grafts placed in 98 patients was evaluated for patency and graft complications. Conducted between 2011 and 2014, the results were published in the March, 2017 Journal of Vascular Surgery, titled "Bovine carotid artery biologic graft outperforms expanded polytetrafluoroethylene for hemodialysis access."

Initially presented at the 2015 symposium of the Society of Clinical Vascular Surgery, 52 grafts (43%) were Artegraft® Bovine Carotid Artery Graft™ (BCA) and 68 (57%) were ePTFE grafts from three major manufacturers.

In the review study, primary and primary assisted patencies were similar for BCA and ePTFE grafts. However, secondary patency was higher for BCA, indicating better durability for the biologic graft than for ePTFE grafts in patients whose anatomy precludes placement of an arteriovenous fistula (AVF).

Graft infection, steal and pseudoaneurysm rates were lower for BCA than for ePTFE.  There was a fivefold increase in mortality associated with ePTFE.

The study concluded that BCA is a durable alternative to AVF in contemporary practice.

About Artegraft
Incorporated in 1993, Artegraft Inc. offers surgeons a clinically proven biological alternative to synthetic grafts and an ideal repair and salvage conduit for a fistula.  Artegraft's natural collagen matrix has proven long-term patency advantages over ePTFE and other synthetic graft materials. Artegraft was the first vascular graft approved by the FDA in 1970 and has been in continuous clinical use for over 45 years. For more information, visit www.artegraft.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/retrospective-study-confirms-bovine-carotid-artery-biologic-graft-outperforms-expanded-polytetrafluoroethylene-for-hemodialysis-access-300433713.html


'/>"/>
SOURCE Artegraft
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Retrospective Study Examining Delcaths CHEMOSAT And Isolated Hepatic Perfusion Presented At ECCO Annual Meeting
2. Health 2.0 Unveils "10 Year Global Retrospective"
3. Advocacy Study Highlights Top Locations for High-Growth Companies
4. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
5. New Study Shows Full Spectrum Endoscopy Procedure Reduces The Miss Rate of Adenomas During Colonoscopy
6. Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak
7. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
8. Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.
9. Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain
10. Ceregene Reports Additional Efficacy Data From Parkinsons Disease Phase 2b Study
11. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/12/2017)...  ValGenesis Inc., the global leader in Enterprise ... announce the appointment of Dr. Ajaz Hussain ... Directors and Chairman of Advisory Board beginning September ... to manage their entire validation lifecycle process electronically ... process. Furthermore, ValGenesis VLMS enables rigorous compliance, helps ...
(Date:9/9/2017)... , Sept. 8, 2017 Dealmed Medical Supplies, ... supplier of medical equipment, supplies, drugs, vaccines, and specialty ... entered into an agreement to acquire Vantage Medical Supplies, ... in Holtsville, New York . ... supplying new and emerging medical practices, will operate under ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in property taxes a year. In some states—like New York, New Jersey, Massachusetts, ... contrast, many overseas retirement havens have extremely low property-tax rates, which contributes to ...
Breaking Medicine News(10 mins):